Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8355326 | 0.84 | MEN1 (0.39) | FDPS | |
| SCHEMBL9352362 | 0.82 | EPHX1 (0.33) | — | |
| SCHEMBL9484958 | 0.77 | ALDH1A1 (0.57) | ALDH1A1LMNAHSD17B10TSHRCYP3A4 | |
| Hydrochloric Acid SCHEMBL21990280 | 0.72 | ALDH1A1 (0.39) | ALDH1A1TSHRCYP3A4TDP1 | |
| SCHEMBL2699370 | 0.71 | — | — | |
| SCHEMBL15131256 | 0.70 | CNR2 (0.31) | — | |
| Butyric Acid SCHEMBL28597114 | 0.69 | FFAR3 (0.50) | ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL15131399 | 0.67 | CRBN (0.32) | LMNATSHRCYP3A4NFKB1 | |
| SCHEMBL277242 | 0.66 | — | — | |
| SCHEMBL22851721 | 0.65 | ALDH1A1 (0.48) | ALDH1A1LMNAHSD17B10TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0392233-B1 | Substituted 1,2,3,4,-Oxatriazolium-5-olates, method for their preparation and their use | CASSELLA FARBWERKE MAINKUR AG (DE) | 1994-09-21 | — | — | EP | disclosed |
| US-5091398-A | Antianginal, antithrombotic | CASSELLA AKTIENGELLSCHAFT (DE) | 1992-02-25 | — | — | US | disclosed |
| EP-0392233-A1 | Substituted 1,2,3,4,-Oxatriazolium-5-olates, method for their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1990-10-17 | — | — | EP | disclosed |